Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Batterham, M.B., B.S., Ph.D., Salvatore Calanna, Ph.D., Melanie Davies, M.D., Luc F
The wide range of muscle loss seen in GLP-1 studies is likely due to differences in how body composition is measured, the type of participants studied, and factors like diet, activity level, and rate of weight loss
TRIUMPH-Outcomes enrolled adults with chronic kidney disease or atherosclerotic cardiovascular disease with obesity, a body mass index (BMI) of 27 or higher
For researchers tracking this space, the key trials to watch in 2026 include the remaining TRIUMPH program readouts for retatrutide, the GLORY-OSA trial for mazdutide in obstructive sleep apnea, and the first Phase 1 data from several quadruple-agonist programs entering clinical development
This meta-analysis reviews the efficacy of Adderall in treating ADHD, providing a synthesis of various clinical trials
We monitor your GIP and GLP-1 receptor sensitivity to determine if a transition will break through the resistance and restart your transformation
